HCA Healthcare, Inc. Website

HCA Healthcare, Inc.

NYSE-HCA

Basic

  • Market Cap

    $88.62B

  • EV

    $132.23B

  • Shares Out

    261.91M

  • Revenue

    $66.72B

  • Employees

    265,000

Margins

  • Gross

    39.65%

  • EBITDA

    19.29%

  • Operating

    14.62%

  • Pre-Tax

    12.04%

  • Net

    8.2%

  • FCF

    8.14%

Returns (5Yr Avg)

  • ROA

    10.14%

  • ROTA

    258.86%

  • ROE

    -17.91%

  • ROCE

    21.72%

  • ROIC

    17.09%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $351.29

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $1,379M

  • Net Debt

    $40.72B

  • Debt/Equity

    33.15

  • EBIT/Interest

    4.95

Growth (CAGR)

  • Rev 3Yr

    8.21%

  • Rev 5Yr

    6.91%

  • Rev 10Yr

    6.79%

  • Dil EPS 3Yr

    14.38%

  • Dil EPS 5Yr

    13.92%

  • Dil EPS 10Yr

    19.43%

  • Rev Fwd 2Yr

    6.24%

  • EBITDA Fwd 2Yr

    5.14%

  • EPS Fwd 2Yr

    10.46%

  • EPS LT Growth Est

    9.33%

Dividends

  • Yield

  • Payout

    12.11%

  • DPS

    $2.46

  • DPS Growth 3Yr

    72.41%

  • DPS Growth 5Yr

    11.15%

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

    5.65%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Total Revenues

51,336

51,533

58,752

60,233

64,968

66,716

Total Revenues % Chg.

10%

0.4%

14%

2.5%

7.9%

9.6%

Cost of Goods Sold, Total

32,041

32,243

36,260

37,056

39,389

40,260

Gross Profit

19,295

19,290

22,492

23,177

25,579

26,456

Selling General & Admin Expenses, Total

855

923

989

976

994

994

Depreciation & Amortization

2,596

2,721

2,853

2,969

3,077

3,116

Other Operating Expenses

8,626

8,384

8,972

10,179

11,881

12,593

Other Operating Expenses, Total

12,077

12,028

12,814

14,124

15,952

16,703

Operating Income

7,218

7,262

9,678

9,053

9,627

9,753

Interest Expense, Total

-1,824

-1,584

-1,566

-1,741

-1,938

-1,971

Net Interest Expenses

-1,824

-1,584

-1,566

-1,741

-1,938

-1,971

Income (Loss) On Equity Invest.

43

54

113

45

22

38

EBT, Excl. Unusual Items

5,437

5,732

8,225

7,357

7,711

7,820

Gain (Loss) On Sale Of Investments

Gain (Loss) On Sale Of Assets

18

-7

1,620

1,301

-5

211

Legal Settlements

Other Unusual Items

-211

-295

-12

-78

EBT, Incl. Unusual Items

5,244

5,430

9,833

8,580

7,706

8,031

Income Tax Expense

1,099

1,043

2,112

1,746

1,615

1,681

Earnings From Continuing Operations

4,145

4,387

7,721

6,834

6,091

6,350

Minority Interest

-640

-633

-765

-1,191

-849

-880

Net Income

3,505

3,754

6,956

5,643

5,242

5,470

Net Income to Common Incl Extra Items

3,505

3,754

6,956

5,643

5,242

5,470

Net Income to Common Excl. Extra Items

3,505

3,754

6,956

5,643

5,242

5,470

Total Shares Outstanding

338.4

339.4

305.5

277.4

265.5

263.2

Weighted Avg. Shares Outstanding

341.2

338.3

323.3

290.3

272.4

269.3

Weighted Avg. Shares Outstanding Dil

348.2

343.6

328.8

294.7

276.4

273.2

EPS

10.3

11.1

21.5

19.4

19.2

20.3

EPS Diluted

10.1

10.9

21.2

19.2

19

20

EBITDA

9,814

9,983

12,531

12,022

12,704

12,869

Effective Tax Rate

21%

19.2%

21.5%

20.3%

21%

20.9%